[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100576391":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":8,"centralContacts":7,"locations":12,"responsibleParty":24,"collaborators":7,"id":26,"slug":27,"hasResults":28,"nctId":29,"briefTitle":30,"officialTitle":31,"acronym":7,"eligibilityCriteria":32,"healthyVolunteers":28,"sex":33,"minAge":7,"maxAge":7,"enrollmentInfo":34,"targetDuration":7,"studyType":37,"phases":7,"briefSummary":38,"conditions":39,"keywords":7,"overallStatus":44,"whyStopped":7,"lastUpdateSubmitDate":45,"lastUpdatePostDateStruct":46,"startDateStruct":48,"completionDateStruct":50,"leadSponsor":52,"locationsCount":53},{"fullName":5,"class":6},"IRCCS Azienda Ospedaliero-Universitaria di Bologna","OTHER",null,[9],{"name":10,"affiliation":5,"role":11},"Simone Bonetti, MD","PRINCIPAL_INVESTIGATOR",[13],{"facility":5,"status":7,"city":14,"state":7,"zip":15,"country":16,"countryCode":17,"cosmosGeoPoint":18,"geoPoint":23,"contacts":7},"Bologna","40138","Italy","IT",{"type":19,"coordinates":20},"Point",[21,22],11.33875,44.49381,{"lat":22,"lon":21},{"type":25,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100576391","evaluation-of-the-prevalence-and-clinical-manifestation-of-sars-cov-2-infection-in-a-population-of-adult-and-pediatric-patients-with-congenital-heart-disease-100576391",false,"NCT06784687","Evaluation of the Prevalence and Clinical Manifestation of SARS-CoV-2 Infection in a Population of Adult and Pediatric Patients With Congenital Heart Disease","Evaluation of the Prevalence and Clinical Manifestation of SARS-CoV-2 Infection in a Population of Adult and Pediatric Patients With Congenital Heart Disease Not Treated Surgically, and in a Population of Pediatric Patients With Cardiomyopathy, Arrhythmic Pathology, or Pulmonary Hypertension","Inclusion Criteria:\n\n* Patients of all ages with congenital heart disease undergoing hemodynamic procedures at our center or in natural history\n* Pediatric patients with cardiomyopathy, arrhythmic disease, or hypertension pulmonary\n* Obtaining informed consent\n* Patients who have access to an e-mail address and a computer to complete the questionnaire\n\nExclusion Criteria:\n\n* Patients with congenital heart disease undergoing corrective or palliative surgical treatment","ALL",{"count":35,"type":36},2376,"ACTUAL","OBSERVATIONAL","The goal of this observational study, drug-free, cross-sectional, single-center is to describe the incidence and characteristics of the clinical course and any short- and medium-term complications of patients with congenital heart disease of medical interest, and pediatric patients with cardiomyopathy, arrhythmic pathology or pulmonary arterial hypertension who have been affected by Sars-Cov-2 disease. The secondary objective of the study is to identify risk factors for the development of moderate-severe forms of COVID-19 disease in the study population.",[40,41,42,43],"Congenital Heart Disease","Cardiomyopathy","Pulmonary Arterial Hypertension","SARS CoV-2 Infection","COMPLETED","2025-01-16",{"date":47,"type":36},"2025-01-20",{"date":49,"type":36},"2021-08-01",{"date":51,"type":36},"2021-12-31",{"name":5,"class":6},1]